Naresuan University

Phitsanulok 65000

0 studies enrolling now · 4 studies all time

What they study most

Advanced Cholangiocarcinoma, Chronic Anemia, Chronic Hepatitis, FGFR2 Gene Mutation, Hepatitis B, Ineffective Erythropoiesis, β-thalassemia

Studies at this site

• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia — Completed
• Safety Study for Beta Thalassemia Subjects on PTG-300 — Completed
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus — Stopped early